Insiders ImpediMed Limited

Equities

Delayed Australian S.E. Other stock markets 20:59:31 2024-05-15 EDT			5-day change	1st Jan Change
0.088 ^AUD	+4.76%		+11.54%	-40.00%

04-30	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
04-30	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

Impedimed Implements Organizational Changes; Makes Strategy Chief, COO Redundant	04-16	MT
Impedimed Names Independent Non-Executive Chair	02-27	MT
ImpediMed CEO, CFO Step Down; Shares Fall 11%	11-19	MT
ImpediMed Limited Announces CEO Changes	11-19	CI
ImpediMed Limited Announces Management Changes	11-19	CI
ImpediMed Limited Announces Resignation of Mrs. Janet West AM as Non-Executive Director	23-10-02	CI
Impedimed Limited Announces Board Changes	23-09-28	CI
ImpediMed Appoints Medical Chief; Shares Down 3%	23-09-26	MT
ImpediMed Limited Announce the Appointment of Steven Chen as Chief Medical Officer	23-09-26	CI
ImpediMed Limited Appoints Daniel Sharp as Director	23-07-03	CI
Impedimed Limited Announces the Appointment of Michael Seiden as Independent Non-Executive Directors, Effective 1 July 2023	23-06-27	CI
Impedimed Appoints Managing Director/CEO	22-11-28	MT
ImpediMed Limited Appoints Richard Valencia as Managing Director, Effective 1 December 2022	22-11-28	CI
Impedimed Limited Announces CEO Changes	22-11-28	CI
Impedimed Reorganizes Management Structure	22-11-22	MT
ImpediMed Limited Announces Management Changes	22-11-21	CI
ImpediMed Limited Announces Board Changes	22-08-29	CI
Impedimed Appoints Interim CEO; Shares Fall 7%	22-07-25	MT
ImpediMed Limited Announces Executive Changes	22-07-25	CI
ImpediMed Limited Announces Resignation of Richard Carreon as Managing Director	22-07-25	CI

No results for this search